EYE FLU (CONJUNCTIVITIS) MARKET ANALYSIS

Regional Analysis

Global Eye Flu (Conjunctivitis) Market- Regional Insights

North America is expected to be the largest market for eye flu (conjunctivitis) market during the forecast period, accounting for over 35.8% of the market share in 2023. North America market growth is attributed to high diagnosis rates, accessibility to advanced treatments, presence of key players and favorable reimbursements.

The Europe market is expected to be the second-largest market for eye flu (conjunctivitis) market, accounting for over 28.2% of the market share in 2023. Europe market growth is attributed to rising prevalence of allergies and government initiatives promoting awareness.

The Asia Pacific market is expected to be the fastest-growing market for eye flu (conjunctivitis) market, with a CAGR of 9.7% during the forecast period. Asia Pacific market growth is attributed to untapped opportunities, improving healthcare expenditure and growing elderly population.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East:  GCC Countries, Israel, and Rest of Middle East  
• Africa: South Africa, North Africa, and Central Africa